September 01, 2016 12:14 AM ET

Biotechnology

Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.26 RelationshipsChairman and Chief Executive Officer52
William J. Dawson 6 RelationshipsChief Financial Officer61
Natalie L. McClure Ph.D.No RelationshipsSenior Vice President of Product Development63
Rajiv Patni M.D.No RelationshipsChief Medical Officer47

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 26 RelationshipsAdamas Pharmaceuticals, Inc.52
David L. Mahoney 43 RelationshipsAdamas Pharmaceuticals, Inc.62
Richard H. Booth CPA, CLU, ChFC 64 RelationshipsLimbach Holdings, Inc.69
Martha J. Demski 35 RelationshipsAjinomoto Althea, Inc.63
William W. Ericson J.D. 156 RelationshipsWildcat Venture Partners57
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski35 Relationships3 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth64 Relationships3 Executives
Nominating Committee David L. Mahoney43 Relationships2 Executives
Corporate Governance Committee David L. Mahoney43 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$425.0K
425.0K
379.6K
Bonus$345.0K
345.0K
261.7K
Total Short Term Compensation
Not meaningful
Total Value of Options$770.0K
770.0K
33.3M
Compensation as of Fiscal Year 2015
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bionomics Ltd. Announces Board Changes
August 30, 2016 11:15 PM ET
Cellceutix Further Expands its Senior Management Team
August 30, 2016 6:07 PM ET
Tizona Therapeutics, Inc. Appoints George Golumbeski to Board of Directors
August 30, 2016 1:00 PM ET
Nutra Pharma Announces Addition of Kenneth Dowd to its Advisory Board
August 30, 2016 12:30 PM ET
Pliant Therapeutics Appoints Suzanne Bruhn, Ph.D., to its Board of Directors
August 30, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.